Drug Shortage Report for TARO-CARBAMAZEPINE

Last updated on 2025-11-11 History
Report ID 262125
Drug Identification Number 02367394
Brand name TARO-CARBAMAZEPINE
Common or Proper name Carba Suspension
Company Name TARO PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) CARBAMAZEPINE
Strength(s) 100MG
Dosage form(s) SUSPENSION
Route of administration ORAL ORAL
Packaging size 450mL
ATC code N03AF
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2025-06-11
Estimated end date 2025-11-07
Actual end date 2025-10-30
Shortage status Resolved
Updated date 2025-11-11
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v24 2025-11-11 French Compare
v23 2025-11-11 English Compare
v22 2025-10-27 French Compare
v21 2025-10-27 English Compare
v20 2025-10-14 French Compare
v19 2025-10-14 English Compare
v18 2025-10-06 French Compare
v17 2025-10-06 English Compare
v16 2025-09-23 French Compare
v15 2025-09-23 English Compare
v14 2025-09-15 French Compare
v13 2025-09-15 English Compare
v12 2025-08-18 French Compare
v11 2025-08-18 English Compare
v10 2025-08-12 French Compare
v9 2025-08-12 English Compare
v8 2025-07-28 French Compare
v7 2025-07-28 English Compare
v6 2025-07-17 French Compare
v5 2025-07-17 English Compare

Showing 1 to 20 of 24